David Egilman

2.6k total citations
69 papers, 1.3k citations indexed

About

David Egilman is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, David Egilman has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 16 papers in Public Health, Environmental and Occupational Health and 14 papers in Pharmacology. Recurrent topics in David Egilman's work include Occupational and environmental lung diseases (23 papers), Pharmaceutical industry and healthcare (13 papers) and Occupational exposure and asthma (13 papers). David Egilman is often cited by papers focused on Occupational and environmental lung diseases (23 papers), Pharmaceutical industry and healthcare (13 papers) and Occupational exposure and asthma (13 papers). David Egilman collaborates with scholars based in United States, United Kingdom and France. David Egilman's co-authors include Joseph S. Ross, Harlan M. Krumholz, Kevin P. Hill, Kevin P. Hill, Corey R. Fehnel, Cristina Candal‐Pedreira, Alberto Ruano‐Raviña, Caroline Lee, Mónica Pérez‐Ríos and Esteve Fernández and has published in prestigious journals such as The Lancet, JAMA and Annals of Internal Medicine.

In The Last Decade

David Egilman

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Egilman United States 19 401 384 298 286 158 69 1.3k
Alice Fabbri Australia 15 360 0.9× 251 0.7× 257 0.9× 30 0.1× 63 0.4× 51 940
Jeanne Lenzer United States 16 235 0.6× 288 0.8× 284 1.0× 85 0.3× 74 0.5× 166 1.3k
Hamilton Moses United States 17 227 0.6× 453 1.2× 447 1.5× 43 0.2× 133 0.8× 33 1.5k
Samuel O. Thier United States 24 133 0.3× 280 0.7× 237 0.8× 317 1.1× 56 0.4× 62 1.8k
Li‐Fang Chou Taiwan 19 62 0.2× 146 0.4× 154 0.5× 58 0.2× 34 0.2× 71 1.5k
David H. M. Matheson United States 4 101 0.3× 315 0.8× 327 1.1× 27 0.1× 88 0.6× 6 901
Umberto Gelatti Italy 31 127 0.3× 365 1.0× 182 0.6× 206 0.7× 6 0.0× 110 3.2k
Jessica A. Myers United States 12 76 0.2× 112 0.3× 232 0.8× 70 0.2× 44 0.3× 21 1.0k
Jane Robertson Australia 26 132 0.3× 274 0.7× 537 1.8× 38 0.1× 29 0.2× 66 2.0k
Sidney M. Wolfe United States 18 213 0.5× 135 0.4× 269 0.9× 53 0.2× 20 0.1× 66 1.6k

Countries citing papers authored by David Egilman

Since Specialization
Citations

This map shows the geographic impact of David Egilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Egilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Egilman more than expected).

Fields of papers citing papers by David Egilman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Egilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Egilman. The network helps show where David Egilman may publish in the future.

Co-authorship network of co-authors of David Egilman

This figure shows the co-authorship network connecting the top 25 collaborators of David Egilman. A scholar is included among the top collaborators of David Egilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Egilman. David Egilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egilman, David, et al.. (2021). A Review of the Talc Industry’s Influence on Federal Regulation and Scientific Standards for Asbestos in Talc. NEW SOLUTIONS A Journal of Environmental and Occupational Health Policy. 31(2). 152–169. 16 indexed citations
2.
Egilman, David, et al.. (2018). Use of Anti-Warnings to Falsely Reassure Downstream Users: An Asbestos Example. NEW SOLUTIONS A Journal of Environmental and Occupational Health Policy. 28(3). 515–538. 2 indexed citations
3.
Egilman, David. (2018). The Production of Corporate Research to Manufacture Doubt About the Health Hazards of Products: An Overview of the Exponent Bakelite® Simulation Study. NEW SOLUTIONS A Journal of Environmental and Occupational Health Policy. 28(2). 179–201. 3 indexed citations
4.
Egilman, David, et al.. (2016). A commentary on Roggli’s “The So-Called Short-Fiber Controversy”. International Journal of Occupational and Environmental Health. 22(3). 181–186. 7 indexed citations
5.
Egilman, David, et al.. (2016). Short fiber tremolite free chrysotile mesothelioma cohort revealed. American Journal of Industrial Medicine. 59(3). 196–199. 5 indexed citations
6.
Baur, Xaver, et al.. (2015). Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health. International Journal of Occupational and Environmental Health. 21(2). 172–175. 11 indexed citations
7.
Egilman, David, et al.. (2013). MetLife and its corporate allies: dust diseases and the manipulation of science. International Journal of Occupational and Environmental Health. 19(4). 287–303. 14 indexed citations
8.
Egilman, David, et al.. (2012). Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series. International Journal of Occupational and Environmental Health. 18(1). 29–42. 17 indexed citations
9.
Egilman, David, et al.. (2011). A Proposal for a Safe Exposure Level for Diacetyl. International Journal of Occupational and Environmental Health. 17(2). 122–134. 19 indexed citations
10.
Maeseneer, Jan De, Richard G. Roberts, Marcelo Demarzo, et al.. (2011). Tackling NCDs: a different approach is needed. The Lancet. 379(9829). 1860–1861. 47 indexed citations
11.
Egilman, David. (2009). Fiber Types, Asbestos Potency, and Environmental Causation: A Peer Review of Published Work and Legal and Regulatory Scientific Testimony. International Journal of Occupational and Environmental Health. 15(2). 202–228. 12 indexed citations
12.
Ross, Joseph C., et al.. (2008). Guest Authorship and Ghostwriting in Publications Related to Rofecoxib. JAMA. 299(15). 1800–1800. 28 indexed citations
13.
Egilman, David, et al.. (2007). Manipulated Data in Shell's Benzene Historical Exposure Study. International Journal of Occupational and Environmental Health. 13(2). 222–232. 9 indexed citations
14.
Egilman, David, et al.. (2007). Against Anti-health Epidemiology: Corporate Obstruction of Public Health via Manipulation of Epidemiology. International Journal of Occupational and Environmental Health. 13(1). 118–124. 11 indexed citations
15.
Egilman, David. (2006). Corporate Corruption of Science—The Case of Chromium(VI). International Journal of Occupational and Environmental Health. 12(2). 169–176. 20 indexed citations
16.
Egilman, David, et al.. (2005). Over a Barrel: Corporate Corruption of Science and Its Effects on Workers and the Environment. International Journal of Occupational and Environmental Health. 11(4). 331–337. 21 indexed citations
17.
Egilman, David, et al.. (1998). Corruption of the medical literature: A second visit. American Journal of Industrial Medicine. 34(4). 401–404. 3 indexed citations
18.
Egilman, David, et al.. (1996). Lung cancer and asbestos exposure: Asbestosis is not necessary. American Journal of Industrial Medicine. 30(4). 398–406. 8 indexed citations
19.
Egilman, David, et al.. (1996). The asbestos TLV: Early evidence of inadequacy. American Journal of Industrial Medicine. 30(3). 369–370. 2 indexed citations
20.
Egilman, David. (1992). Public health and epistemology. American Journal of Industrial Medicine. 22(3). 457–459. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Fabbri Breakdown of academic impact, for papers by Jeanne Lenzer Breakdown of academic impact, for papers by Hamilton Moses Breakdown of academic impact, for papers by Samuel O. Thier Breakdown of academic impact, for papers by Li‐Fang Chou Breakdown of academic impact, for papers by David H. M. Matheson Breakdown of academic impact, for papers by Umberto Gelatti Breakdown of academic impact, for papers by Jessica A. Myers Breakdown of academic impact, for papers by Jane Robertson Breakdown of academic impact, for papers by Sidney M. Wolfe
Rankless by CCL
2026